Corporate Profile News Products and Services Learning Center Patients Doctors & Distributors Contact Us
 
About Lerner Medical
Investor Relations
Management
Employment Opportunities
About Lerner Medical
Lerner Medical Devices, Inc. is focused on the use of light to treat skin disease. Our mission is to develop, manufacture and market devices that utilize advanced HIFOL (High Intensity Fiber Optic Light) optical technology to provide novel phototherapeutic approaches to skin conditions and disease. Our initial product for office based phototherapy has been cleared by the FDA and has been licensed to the Daavlin Company (www.daavlin.com) which has introduced it to market as the Lumera™ Targeted Phototherapy System. Our second market is the patient for whom our personal Levia™ system will offer the convenience of self-administered phototherapy. The Company intends to leverage its technology and expertise in developing other products using light for medical applications.
 
Our Mission
It is our mission to develop the Levia LiteBrush™ technology for home use to facilitate treatment of scalp psoriasis. As the company grows it will seek other underserved areas of skin disease with innovative approaches.

Company History and Profile
Lerner Medical Devices, Inc. was founded in 2001 by Dr. Ethan Lerner and Dr. Michael Lerner to pursue novel approaches to the treatment of skin diseases.

The Company has operated from its current location in West Los Angeles since the beginning of 2003 and instituted an optical research and development laboratory for testing the various design elements of its devices.

The Company has developed and patented a novel medical device to treat psoriasis of the scalp and other skin conditions. The Company’s initial product utilizes our HIFOL technology (High Intensity Fiber Optic Light) and the patented LiteBrush™. It has received 510(k) clearance from the FDA for the treatment of psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis (dandruff), and leucoderma (stretch marks). The device consists of an ultraviolet light source linked to fiberoptic “bristles” configured in a hairbrush arrangement to deliver phototherapy to the scalp. It has been tested successfully in a clinical trial for scalp psoriasis at the Massachusetts General Hospital. To the Company’s knowledge, there is no other effective phototherapeutic treatment that delivers light directly to the scalp to treat psoriasis. The Company has licensed this initial product to the Daavlin Company (www.daavlin.com), a worldwide leader in phototherapy. Daavlin has introduced the product to market as the Lumera™ for the dermatologist and phototherapy clinics.

A commitment to Patient Needs
Lerner Medical Devices, Inc. is committed to explore all areas where light can benefit patients on the surface of the body or inside. In every endeavor we enter, from innovation to product development planning, till the final launch, the needs and benefits of the patient are our driving force.

 
top

©2003-08 Lerner Medical Devices, Inc. All Rights Reserved.